Analysis of in vitro toxicity of five cell-penetrating peptides by metabolic profiling

Kalle Kilk1, Riina Mahlapuu, Ursel Soomets

  • 1Department of Biochemistry, Medical Faculty, University of Tartu, The Centre of Excellence for Translational Medicine, 50411 Tartu, Estonia. kalle.kilk@ut.ee

Toxicology
|October 6, 2009
PubMed

Insights

Cell-penetrating peptides (CPPs) show potential for drug delivery, but can impact cell health. Metabolomic analysis revealed transportan (TP) significantly altered cell metabolism and homeostasis, indicating toxicity.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Pharmacology

Background:

  • Cell-penetrating peptides (CPPs) are explored as safe and efficient delivery vectors for various cargoes.
  • Cellular internalization of compounds can disrupt cell homeostasis, necessitating toxicity assessments.
  • Omics studies are valuable for identifying unexpected side-effects and evaluating drug candidate toxicity.

Purpose of the Study:

  • To compare the effects of five common CPPs on the cytosolic metabolome of Chinese Hamster Ovary (CHO) cells.
  • To identify potential toxicity and side-effects associated with CPP internalization.
  • To evaluate the safety profile of different CPPs as delivery vectors.

Main Methods:

  • Liquid chromatography-mass spectrometry (LC-MS) was employed to analyze the cytosolic metabolome of CHO cells.
  • Principal component analysis (PCA) and heatmap displays were used to interpret the metabolomic data.
  • Comparative analysis of five CPPs: transportan (TP), penetratin (pAntp), HIV Tat peptide (pTat), nonaarginine (R(9)), and model amphipathic peptide (MAP).

Main Results:

  • Transportan (TP) caused the most significant alterations in the intracellular metabolome, followed by pTat and MAP.
  • Penetratin (pAntp) and nonaarginine (R(9)) treatments resulted in only minor metabolic changes.
  • TP treatment at 5 microM allowed cell recovery, but higher concentrations did not.
  • TP was found to affect cellular redox potential, deplete energy, and alter purine and pyrimidine pools.

Conclusions:

  • Metabolomic profiling is an effective approach for comparing the safety of CPPs.
  • Transportan (TP) exhibits toxicity by disrupting cellular energy, redox balance, and nucleotide pools.
  • The findings highlight the importance of assessing CPP-induced metabolic changes to ensure safe drug delivery applications.

Related Concept Videos